(1) Identify factors associated with online patient ratings and comments for a nationwide sample of otolaryngologists.
Objectives:
(1) Complete cost-saving analysis of data collected for a study examining Telehealth in voice therapy in pediatric dysphonia patients. (2) Examine basic feasibility of voice therapy using Telehealth technology. Children with voice disorders frequently travel long distances to establish their care with pediatric voice specialists. Access to these services can pose significant problems for families seeking voice improvement for their child. Evidence has shown that web-based behavioral therapy modalities are efficacious and desirable; however, few have reported use in childhood communication disorders or potential cost savings.
Methods: We performed an outcome analysis of data collected for a Telehealth intervention study of 10 children, aged 8 to 15 years (and their parents/caregivers) who were referred for voice therapy for the treatment of a voice disorder. We analyzed the cost-saving factors of Telehealth over in-person treatment sessions. Potential savings examined include cost of travel, childcare, meals, missed work, missed school, and travel time.
Results: Nine participants had cost data available for analysis from 2 to 6 surveys over 11 weeks of sessions (majority at least 5 surveys). The median cost savings was $10.00 per session (range $3-81). Other unquantified monetary cost savings came in the form of childcare (5%) and meals (42%). In addition, 56% of participants did not have to miss work, saving 3.9 ± 2.4 hours. Some 78% of participants did not have to miss school, saving 2.5 ± 1.6 hours away from school per session.
Conclusions: Telehealth is a potentially cost-saving and feasible method for providing speech therapy. Future work is needed to explore Telehealth delivered voice therapy.
Departments in Transition: A New Paradigm for Progress
Jennifer A. Villwock, MD (presenter); Chelsea S. Hamill, MD; Kevin J. Sykes, PhD, MPH; Alexander G. Chiu, MD Objectives: (1) Understand the function and process of an organizational assessment. (2) Appreciate the role of strategic plans for the development of needed departmental programs.
Methods: We developed a needs assessment survey for an academic otolaryngology department largely based on existing corporate literature. Adapting this information to academic medicine, we assessed the work environment, capacity for change, and current priorities. This was administered to all department personnel. Real-time analysis of survey responses 
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P41 allowed for development of unified department priorities and identification of opportunities for improvement. Focus groups, involving staff at all levels, then developed specific projects to advance a strategic plan.
Results: A total of 91 staff participated in the survey and focus groups. Overall, the department has a solid foundation of high job satisfaction and collaborative environment. Six main strategic missions were defined: health care delivery research, internal and external communication, clinical operations, continuing medical education, mentorship, and quality improvement. Within each of these domains, 1 to 2 action items to be completed over the calendar year were further developed. Examples of this included a formalized mentorship program to include residents as well as academic and community faculty, a plan to optimize clinic space utilization and workflow, and a focused effort to expand clinical outcomes research to include patient-and provider-centered metrics and quality improvement.
Conclusions: A needs assessment was successfully utilized in an academic otolaryngology department to determine the current culture, priorities, and strengths. This allowed for focus groups to identify strategic missions and targeted projects through which to achieve them.
FDA Clearance of Medical Devices via the 510(k) Process
Vinay K. Rathi, MD (presenter); Shekhar Gadkaree, MD; Elliott D. Kozin, MD; Matthew R. Naunheim, MD, MBA; Rosh K. Sethi, MD, MPH; Stacey T. Gray, MD Objectives: The US Food and Drug Administration (FDA) clears moderate-risk devices for marketing via the 510(k) process based on "substantial equivalence" to existing devices; evidence of safety and effectiveness is not required. The aims of this presentation are (1) examine the FDA 510(k) clearance process, (2) characterize otolaryngologic devices cleared via the 510(k) process, and (3) describe premarket evidence supporting FDA clearance of otolaryngologic devices.
Methods: We conducted a cross-sectional analysis using publicly available FDA documents to characterize moderaterisk otolaryngologic devices and premarket evidence supporting FDA clearance. Supporting evidence was categorized by type (clinical/nonclinical/none).
Results: Between 1997 and 2016, the FDA cleared 377 moderate-risk otolaryngologic devices via the 510(k) process. Approximately one-third (n = 137; 36.3%) were diagnostic (eg, audiometers and rhinomanometers), and two-thirds (n = 240; 63.7%) were therapeutic (eg, ossicular prostheses and vocal fold injectables). The large majority (n = 311; 82.5%) of devices were otologic. Roughly one-third (n = 121; 32.1%) were implantable. Few (n = 10; 2.7%) devices were subject to FDA recall. FDA summaries describing premarket evidence were available for 247 (65.5%) devices. Among these devices, a minority (n = 66; 26.7%) were supported by clinical evidence; most (n = 177; 71.7%) were supported by nonclinical evidence, although nearly one-quarter (n = 59; 23.9%) were cleared without supporting evidence. Therapeutic devices were more often cleared without supporting evidence (therapeutic: 53/170 [31.2%], diagnostic: 5/77 [6.5%]; P < .0001).
Conclusions: The FDA clears many commonly-used otolaryngologic devices for marketing via the 510(k) process without clinical evidence of safety and effectiveness. Otolaryngologists should be aware of limitations in premarket evidence when considering the adoption of new devices into clinical practice.
Medical Malpractice and Vestibular Schwannoma
Hamid Djalilian, MD (presenter); Kimberly Vu; Kasra Ziai, MD; Omid Moshtaghi; Hossein Mahboubi, MD, MPH; Ronald Sahyouni; Harrison Lin, MD Objectives: To analyze litigation trends and characteristics of lawsuits involving acoustic neuromas.
Methods: A case series analysis was performed using 2 major computerized legal databases (LexisNexis and WestLaw) to identify all US state and federal civil trials alleging malpractice and acoustic neuromas or vestibular schwannoma from 1976 to 2016. A total of 34 cases were identified by these criteria.
Results: Allegations were divided into 4 categories: misdiagnosis/delayed diagnosis (50%), postoperative complications (41%), failure of informed consent or information sharing (15%), and other (3%). The postoperative complications included facial nerve paralysis, myocardial infarction, meningitis, and intracranial hemorrhage. Settlement amounts ranged from $300,000 to $15,787,555. Of the 24 cases with discernible physician specialties, the breakdown is as follows: otolaryngologists (46%), neurosurgeons (33%), primary care physicians (12%), neurologists (12%), radiologists (12%), anesthesiologists (8%), and radiation oncologists (3%). Of those cases, 29% listed 2 physicians as defendants.
Conclusions: Our study shows that both surgical and nonsurgical specialists are implicated in malpractice lawsuits involving acoustic neuroma diagnosis, postoperative complications, and informed consent. Half of the lawsuits involved otolaryngologists and neurosurgeons, but other nonsurgical specialties also were targets of these lawsuits. A multidisciplinary collaboration and modalities to expedite diagnosis, outcomes, and communication and to ensure that patients understand the risks and benefits of procedures should be considered as part of the risk management goals in the future.
Otolaryngology resident Preparedness for Fellowship
Cristina Cabrera-Muffly, MD (presenter); Julie A. Highland
Objectives: (1) Evaluate fellowship program director's perceptions of incoming clinical fellows preparedness for subspecialty training within 5 domains: professionalism, independent and graduated practice, psychomotor ability, clinical evaluation and management, and research and academic ability. (2) Identify strengths and shortcomings in otolaryngology training programs' ability to prepare residents for fellowship. Presentation schedule is subject to change. The Official Program Abstracts supplement does not reflect changes made after August 17, 2017. Methods: A validated survey by the American College of Surgeons was modified and distributed to fellowship program directors in 6 otolaryngology subspecialties: pediatric otolaryngology, rhinology, laryngology, facial plastic and reconstructive surgery, neurotology and otology, and head and neck oncologic surgery. The 59-item survey employed a 5-response Likert scale tailored to each subspecialty. Responses were collected between November 2016 and January 2017.
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Results: In total, 110 otolaryngology faculties responded to the survey (52%). Respondents had worked with fellows for a mean of 12 years (SD 8). Respondents felt that fellows were competent in the areas of professionalism and clinical evaluation and management. Pediatric faculties were more likely to disagree about fellows' independence in the operating room (P = .004) and during call (P = .002) compared with other specialties. Laryngology and facial plastic faculties felt more neutral about anatomy recognition (P = .008), tissue manipulation (P = .002), and use of energy sources (P < .001). Fellows were felt to be least prepared in research and academic ability.
Conclusions: Faculties involved in fellowship training feel that fellows are well prepared overall upon entering fellowship. Regardless of specialty, residents applying for fellowship could benefit from increased training in research design, data analysis, and basic statistics.
Safety and Efficacy of Outpatient Parotidectomy
Andrea M. Ziegler, MD (presenter); Eric Thorpe, MD Objectives: (1) Compare the rate of postoperative complications and extent of postoperative care in patients undergoing an outpatient parotidectomy compared with an inpatient parotidectomy.
(2) Analyze the direct cost difference to the hospital for outpatient compared with inpatient parotidectomy.
Methods: This is a retrospective review of patients who underwent a parotidectomy at 1 tertiary care university hospital between 2007 and 2016. Patients were excluded from the study if any additional procedures were performed at the same time, such as a neck dissection. Patient variables were collected including analysis of comorbidities using the American Society of Anesthesiologists physical status classification and the Charlson comorbidity index. Postoperative complication rates including facial nerve weakness, wound infection, hematoma or seroma formation, emergency department (ED) visits, and readmission rates were collected, as well as the number of postoperative visits and telephone encounters. Finally, the cost difference between inpatient and outpatient parotidectomy was analyzed.
Results: A total of 502 patients were included in this study. There was no significant difference in patient comorbidities between the inpatient and outpatient group. There was no increased rate of postoperative complications in the outpatient group. There were significantly less postoperative visits in the outpatient parotidectomy group. No patient in the outpatient group visited the ED or required readmission. On average at our institution, outpatient parotidectomy directly costs the hospital $1200 less than an inpatient parotidectomy.
Conclusions: Outpatient parotidectomy can be performed safely and cost-effectively in select patients with no increased risk of complications.
What Do Patients Want from
Otolaryngologists? Matthew R. Naunheim, MD, MBA (presenter); Vinay K. Rathi, MD; Blake C. Alkire, MD; Allen C. Lam, MD; Phillip C. Song, MD; Mark G. Shrime, MD, PhD, MPH Objectives: (1) Implement a discrete choice experiment (DCE) to assess patient preferences in otolaryngologic care.
(2) Describe key attributes that influence patient decision making.
(3) Determine willingness to pay for components of otolaryngology clinic visits Methods: A DCE survey including 5 key attributes (wait time, physician experience, physician personality, utilization of visit time, and cost/copayment) was constructed using structured qualitative interviews with patients and experts. The computer-based survey was administered to volunteers from the general population. Participants chose between hypothetical otolaryngology visits, which varied across these attributes. Demographic and socioeconomic data were collected. A conditional logit model was used to determine the relative importance of attributes.
Results: A total of 161 participants were included. Cost/copayment had the greatest impact on decision making (importance 32.2%), followed by wait time and physician experience (importance 26.5% and 24.7%, respectively). Physician personality mattered least (importance 4.7%); however, all 5 attributes were significantly correlated with patient decision making (P < .01). Patients preferred doctors who spent the majority of the visit performing physical examination. Patients were willing to pay $52 extra to avoid a 4-week delay in appointment time, $87 extra for a physician with 10 years of experience (as opposed to 0), and $9 extra for a doctor who was caring and friendly (as opposed to formal and efficient).
Conclusions: DCEs allow for powerful economic analyses that help physicians understand patient preferences. Our model shows that (1) cost is an important factor in patient decision making and (2) patients prefer and are willing to pay for otolaryngologists who offer timely appointments, experience, and thorough physical examination.
Endocrine Surgery
Cost-utility Analysis of Pediatric Grave's Therapy Prasanth Pattisapu, MD, MPH (presenter); Ioanna Athanassaki, MD; Ashish Deshmukh, PhD, MPH; Deepak Mehta, MD, FRCS; Haejin In, MD, MBA, MPH; Daniel C. Chelius, MD Objectives: (1) Analyze cost-effectiveness of early total thyroidectomy (eTT) with standard treatments for pediatric Grave's disease (PGD). (2) Explore sensitivity of costeffectiveness models to expected outcomes/complications.
